Terminator 2 Register

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
All patients with chronic HBeAg negative hepatitis B treated with nucleos(t)ide analogues, who discontinue treatment based in the criteria outlined in the EASL hepatitis B guidelines shall be included in the present study. The aim is to evaluate the clinical outcome (virological relapse, HBsAg decline) and associated virological and immunological parameters.
Epistemonikos ID: 00a66eba143d45211d544c107873dc1e9380a175
First added on: May 21, 2024